Cargando…
Synergistic Antitumor Activity from Two-Stage Delivery of Targeted Toxins and Endosome-Disrupting Nanoparticles
[Image: see text] Plant-derived Type I toxins are candidate anticancer therapeutics requiring cytosolic delivery into tumor cells. We tested a concept for two-stage delivery, whereby tumor cells precoated with an antibody-targeted gelonin toxin were killed by exposure to endosome-disrupting polymer...
Autores principales: | Su, Xingfang, Yang, Nicole, Wittrup, K. Dane, Irvine, Darrell J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2013
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646422/ https://www.ncbi.nlm.nih.gov/pubmed/23444913 http://dx.doi.org/10.1021/bm3019906 |
Ejemplares similares
-
Antibody–Drug Conjugate that Exhibits Synergistic
Cytotoxicity with an Endosome–Disruptive Peptide
por: Knewtson, Kelsey E., et al.
Publicado: (2019) -
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
por: Schmid, Daniela, et al.
Publicado: (2017) -
Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies
por: Lutz, Emi A., et al.
Publicado: (2022) -
A Nonpolycationic Fully Proteinaceous Multiagent System for Potent Targeted Delivery of siRNA
por: Liu, David V, et al.
Publicado: (2014) -
Shaping humoral responses against mini-libraries of HIV env antigens via lipid nanoparticle vaccine delivery
por: Hanson, MC, et al.
Publicado: (2012)